Regulatory Analysis

FDA regulatory intelligence, warning letter breakdowns, and actionable analysis for brands across all FDA-regulated categories.

Warning Letter Analysis8 min read

30 FDA Warning Letters in a Day: Inside the GLP-1 Compounding Crackdown and the Case That Sent Three Patients to the ER

The FDA issued 30 warning letters to compounded GLP-1 telehealth companies on March 3, 2026. One documented ER visits from bacterial endotoxin contamination. A deep-dive into the violations—and what every compounding pharmacy must do now.

Read article →
30 FDA Warning Letters in a Day: Inside the GLP-1 Compounding Crackdown and the Case That Sent Three Patients to the ER

What if this analysis was about YOUR products?

Policy Canary monitors the FDA for your specific products — by name, by ingredient, by facility. Start your free trial.

Start Free Trial